Swissmedic is Switzerland's therapeutic-products regulator and operates the national pharmacovigilance system for human medicinal products.
Core official resources
- Pharmacovigilance — central Swissmedic pharmacovigilance information and reporting framework.
- Reporting suspected adverse drug reactions by pharmaceutical companies — company electronic reporting through ElViS or gateway connections.
- Vigilance system — entry point to pharmacovigilance and other vigilance reporting systems.
Practical use
Swissmedic accepts company ICSR submissions electronically through ElViS or gateway routes. The reporting pages also publish current technical information and responsible-person materials, so they should be checked whenever interfaces or procedural requirements change.